November 14, 2024CorporateTerumo Blood and Cell Technologies Unlocks New Chapter of Localization in China to Facilitate Blood and Cell Treatment Options for Patients
November 12, 2024CorporateTerumo Blood and Cell Technologies Merges Therapeutics Units to Enhance Patient Care Across Treatment JourneyNew Global Therapy Innovations business unit, led by Veerle d’Haenens, aims to unify therapeutic apheresis and cell and gene therapy expertise to expand therapeutic possibilities
November 07, 2024FinancialNotice Concerning Revisions to Full-Year Consolidated Financial Guidance for Fiscal Year Ending March 31, 2025 (FY2024) (PDF 85.27 KB)
Refining Searches 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Corporate Financial August 08, 2014 Corporate Announcement of a New Corporate Logo Mark August 06, 2014 Financial Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 56.35 KB) May 20, 2014 Corporate Terumo BCT Enters Agreement with Kaneka CorporationMulti-year collaboration agreement for the combined use of therapeutic apheresis and columns for LDL reduction May 15, 2014 Corporate Terumo® Launches Expanded GLIDEWAY™ Access Sheath Portfolio With A New Product For Minimally Invasive Urologic Procedures New GLIDEWAY™ Ureteral Access Sheath Offers Advanced Features Designed to Minimize Trauma May 08, 2014 Financial Notice Concerning the Renewal of a Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures) (PDF 129.84 KB) April 24, 2014 Corporate New Candidate for Independent Director April 24, 2014 Corporate Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA) April 02, 2014 Corporate Terumo Expands Sales Collaboration in Japan with Biosensors for Nobori® DES and Extends Licensing Agreement to Sell the Product Overseas March 27, 2014 Corporate Election of New Board Members March 25, 2014 Corporate Terumo BCT Becomes Therakos Inc. Distributor in Latin America Multi-year agreement enables Terumo BCT to provide Therakos products in several Latin American countries March 14, 2014 Corporate Terumo Announces Exclusive Acquisition Right Agreement with French Bioresorbable Scaffold Company, "ART" February 12, 2014 Corporate Terumo Wins Pharmapack 2014 Award For Nanopass® 34 Pen-Needle In The Category "Quality Of Life" February 03, 2014 Corporate Terumo Receives CE Mark for Its New Drug-eluting Stent, Ultimaster™ January 28, 2014 Corporate Nonin Medical Announces U.K. and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart™ Universal Oximetry System January 28, 2014 Corporate U.S. Food and Drug Administration Clears Granulocyte Collection Procedure on the Spectra Optia Apheresis System Granulocyte, or polymorphonuclear [PMN] cell, collections on the next-generation therapeutic apheresis platform to optimize cellular collections and supplement current protocol offering Pagination Previous page ‹ Page1 … Page8 Page9 Current page10 Next page ›
August 06, 2014 Financial Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 56.35 KB)
May 20, 2014 Corporate Terumo BCT Enters Agreement with Kaneka CorporationMulti-year collaboration agreement for the combined use of therapeutic apheresis and columns for LDL reduction
May 15, 2014 Corporate Terumo® Launches Expanded GLIDEWAY™ Access Sheath Portfolio With A New Product For Minimally Invasive Urologic Procedures New GLIDEWAY™ Ureteral Access Sheath Offers Advanced Features Designed to Minimize Trauma
May 08, 2014 Financial Notice Concerning the Renewal of a Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures) (PDF 129.84 KB)
April 24, 2014 Corporate Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA)
April 02, 2014 Corporate Terumo Expands Sales Collaboration in Japan with Biosensors for Nobori® DES and Extends Licensing Agreement to Sell the Product Overseas
March 25, 2014 Corporate Terumo BCT Becomes Therakos Inc. Distributor in Latin America Multi-year agreement enables Terumo BCT to provide Therakos products in several Latin American countries
March 14, 2014 Corporate Terumo Announces Exclusive Acquisition Right Agreement with French Bioresorbable Scaffold Company, "ART"
February 12, 2014 Corporate Terumo Wins Pharmapack 2014 Award For Nanopass® 34 Pen-Needle In The Category "Quality Of Life"
January 28, 2014 Corporate Nonin Medical Announces U.K. and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart™ Universal Oximetry System
January 28, 2014 Corporate U.S. Food and Drug Administration Clears Granulocyte Collection Procedure on the Spectra Optia Apheresis System Granulocyte, or polymorphonuclear [PMN] cell, collections on the next-generation therapeutic apheresis platform to optimize cellular collections and supplement current protocol offering
Top
Top